KATRINA GIPSON: Open Payments
NPI 1366008500 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 63 payments from 24 companies in 2025. Trend: 2023 $1,429 · 2024 $1,521 · 2025 $1,718
Food & beverage: $1,347Education: $371
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $309 |
| ABBVIE INC. | 7 | $277 |
| Daiichi Sankyo Inc. | 7 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $167 |
| Alexion Pharmaceuticals, Inc. | 3 | $126 |
| BeOne Medicines USA, Inc. | 4 | $78 |
| TerSera Therapeutics LLC | 2 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Stemline Therapeutics Inc. | 3 | $48 |
Products named: Enhertu, EPKINLY, IMBRUVICA, Nubeqa, TALVEY, DARZALEX, BRUKINSA, ERLEADA.
Industry payments across LA — which companies pay providers there.
